Skip to main content
Clinical Trials/CTRI/2022/02/040243
CTRI/2022/02/040243
Not Yet Recruiting
N/A

ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE AND DRUG THERAPY MANAGEMENT FOR WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS)

I0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: N948- Other specified conditions associated with female genital organs and menstrual cycle
Sponsor
I
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
I

Eligibility Criteria

Inclusion Criteria

  • Out\-patients of Department of Obstetrics \& Gynaecology and IVF Center Kshema, Department of Endocrinology, Department of Dermatology. Women aged 15\-45 years, Patients with physical symptoms of PCOS, Women with biochemical abnormalities or polycystic ovaries visualized in ultra sound, Patients who are willing to participate in the study.

Exclusion Criteria

  • Women who are not willing to Participate, Patients who provide incomplete information.

Outcomes

Primary Outcomes

Not specified

Similar Trials